← All organizations
Highest phase reached
Phase 4
First clinical trial
Jan 31, 2016Last known activity
Nov 1, 2023
Timeline
No events for the selected filters.
Drugs by trial phase (7 distinct, 8 trials)
Phase 4 (1 own, 0 via acquisition)
Phase 3 (3 own, 0 via acquisition)
Phase 1 (1 own, 0 via acquisition)
Other trials (2 own, 0 via acquisition)
Recent trials (14)
- NCT06080802Lead sponsorPhase 2/Phase 3Nov 1, 2023
- NCT05847244Sponsor investigatorPhase 2Oct 1, 2023
- NCT05847244Lead sponsorPhase 2Oct 1, 2023
- NCT05816707Lead sponsorPhase 1May 1, 2023
- NCT05816707Sponsor investigatorPhase 1May 1, 2023
- NCT06650280Sponsor investigatorN/AFeb 1, 2023
- NCT06650280Lead sponsorN/AFeb 1, 2023
- NCT05746676Lead sponsorPhase 3Jan 12, 2023
- NCT05746676Reponsible party - principal investigatorPhase 3Jan 12, 2023
- NCT05730153Reponsible party - principal investigatorPhase 4Nov 21, 2021
- NCT05730153Lead sponsorPhase 4Nov 21, 2021
- NCT04366869Lead sponsorN/AJul 7, 2019
- NCT04366869Reponsible party - principal investigatorN/AJul 7, 2019
- NCT03716765Study directorN/AJan 31, 2016
Details
- Last known activity
- Nov 1, 2023